期刊文献+

负载凋亡肿瘤细胞的树突状细胞对喉癌细胞的杀伤作用

Killing effect of apoptotic-tumor-cell-loaded dendritic cells on laryngeal carcinoma cells
原文传递
导出
摘要 目的探讨凋亡肿瘤细胞抗原负载的树突状细胞(DC)对喉癌细胞杀伤作用的影响。方法用细胞因子重组人白细胞介素4(rhIL-4)、重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)与肿瘤坏死因子α(rhTNF-α)体外诱导扩增人外周血单个核来源的DC,6 d后将DC分为凋亡组、冻融组和未处理组;各组细胞继续培养4 h后,分别采用流式细胞术检测DC表面分子的表达、ELISA法检测干扰素γ(IFN-γ)的水平、MTT法评估各组DC刺激细胞毒性T淋巴细胞(CTL)增殖的能力及诱导CTL的杀伤活性。结果与其余各组相比,凋亡组DC表面分子与IFN-γ的表达明显增加(P<0.05),CTL的增殖能力与杀伤活性增强(P<0.05)。结论凋亡肿瘤细胞可以促进DC的分化与成熟,并能使DC产生高效而特异性的抗喉癌免疫应答。 Objective To explore the killing effect of apoptotic-tumor-cell-loaded dendritic cells( DCs) on the laryngeal carcinoma cells. Methods DCs from peripheral blood monocytes were induced by recombinant human interleukin-4( rhIL-4),recombinant human granulocyte/macrophage colony-stimulating factor( rhGM-CSF) and tumor necrosis factor( TNF-α) in vitro,then were divided into the apoptotic laryngeal carcinoma cells group,freeze-thaw cells group and untreated cells group 6 days later. After continuous culture of DCs for 4h,the expressions of the surface markers of DCs were detected by flow cytometry,the level of Interferon-γ( IFN-γ) was measured by ELISA,and the proliferation ability and killing effect of cytotoxic T lymphocyte( CTL) stimulated by DCs were evaluated by MTT. Results Compared with other groups,apoptotic laryngeal carcinoma cells group could enhance the expression of the surface markers CD83,CD86,HLA-DR and IFN-γ( P〈 0. 05),and the proliferation ability and killing effect of CTL increased( P〈 0. 05). Conclusion Apoptotic carcinoma cells can promote the differentiation and maturation of DCs,and induce effective and specific immune response against laryngeal carcinoma.
作者 张敏 王雪峰
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第7期32-36,共5页 Journal of Shandong University:Health Sciences
基金 辽宁省科学技术计划项目(2012225019)
关键词 凋亡肿瘤细胞 顺铂 树突状细胞 喉癌细胞 Apoptotic carcinoma cells Cisplatin Dendritic cell Laryngeal carcinoma cell
  • 相关文献

参考文献15

  • 1Gao C, Pan J, Lu W, et al. In-vitro evaluation of paclita- xel-loaded MPEC-PLGA nanoparticles on laryngeal carci- noma cells[J]. Anticancer Drugs, 2009, 20(9) :807-814. 被引量:1
  • 2Ueno H, Klechevsky E, Morita R, et al. Dendritic cell subsets in health and disease [ J ]. Immunol Rev, 2007, 219 : 118-142. 被引量:1
  • 3SU X, Zhang L, Jin L, et al. Coculturing dendritic ceils with zoledronate acid efficiently enhance the anti-tumor effect of cytokine-induced killer cells [ J ]. J Clin Immu- nol, 2010, 30(5) :766-774. 被引量:1
  • 4冯勤梅,吴霞,王颖,葛海良,狄文.紫杉醇和顺铂诱导下的凋亡卵巢癌细胞对树突细胞提呈功能影响[J].细胞与分子免疫学杂志,2009,25(1):38-41. 被引量:2
  • 5Koski G K, Cohen P A, Roses R E, et al. Reengineering dendritic cell-based anti-cancer vaccines [J]. Immunologi- cal Rev, 2008, 222:256-276. 被引量:1
  • 6Yu X, Xia W, Zhang T, et al. Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cyto- kine-induced killer cells to hepatocellular carcinoma cells [J]. Int J Hematol, 2010, 92(2) :276-282. 被引量:1
  • 7Ellebaek E, Engell-Noerregaard L, Iversen T Z, et al. Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophospha- mide: results from a phase II trial [ J ]. Cancer Immunol Immunother, 2012, 61 (10) :1791-1804. 被引量:1
  • 8Nasr N, Harman A, Turville S, et al. HIV infection of dendritic cells [ J ]. Methods Mol Biol, 2014, 1087 : 221- 232. 被引量:1
  • 9Gregori S. Dendritic cells in networks of immunological tolerance[J]. Tissue Antigens, 2010, 77(2) :89-99. 被引量:1
  • 10Pinzon-Charry A, Ho C S, Maxwe T, et al. Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer[J]. Br J Cancer, 2007, 97 (9) :1251-1259. 被引量:1

二级参考文献7

  • 1Correale P, Cusi MG, Del Vecchio MT, et al. Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro[ J]. J Immunol, 2005, 175(2) : 820 -828. 被引量:1
  • 2Coukos G, Conejo-Gareia JR, Ronder RB, et al. Immunotherapy for gynaecological malignancies [ J ]. Expert Opin Biol Ther, 2005,5 (9) : 1193 - 1210. 被引量:1
  • 3Vari F, Hart DN. Loading DCs with Ag [ J ]. Cytotherapy, 2004, 6 (2): 111-121. 被引量:1
  • 4Ward S, Casey D, Labarthe MC, et al. Immunotherapeutic potential of whole tumor cells [ J ]. Cancer Immunol Immunother, 2002, 51 (5) : 351 -357. 被引量:1
  • 5Nowak AK, Lake RA, Marzo AL, et ol. Induction of tumor cell apoptosis in vivo increases tumor antigen eross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells[ J]. J Immunol, 2003, 170(10) : 4905 -4913. 被引量:1
  • 6Van der Most RG, Currie A, Robinson BW, et al. Cranking the iramunologic engine with chemotherapy : using context to drive tumor antigen cross-presentation towards useful antitumor immunity[ J]. Cancer Res, 2006, 66(2) : 601 -604. 被引量:1
  • 7Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death [ J ]. J Exp Med, 2005, 202(12) : 1691 - 1701. 被引量:1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部